Drug Shortage Report for REVATIO

Last updated on 2018-12-18 History
Report ID 63649
Drug Identification Number 02341611
Brand name REVATIO
Common or Proper name REVATIO
Company Name PFIZER CANADA ULC
Active Ingredient(s) SILDENAFIL
Strength(s) 0.8MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1x 12.5ML VIAL
ATC code C02KX
ATC description OTHER ANTIHYPERTENSIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-10-09
Estimated end date
Actual end date 2018-12-17
Shortage status Resolved
Updated date 2018-12-18
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-12-18 English Compare
v8 2018-12-17 French Compare
v7 2018-12-17 English Compare
v6 2018-12-17 English Compare
v5 2018-12-13 French Compare
v4 2018-12-13 English Compare
v3 2018-10-10 French Compare
v2 2018-10-10 English Compare
v1 2018-10-10 English Compare